Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis
Catherine R. Weiler
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 8, Iss. 2, pp. 498-506
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
Robert W. Malone, Philip Tisdall, Philip Fremont‐Smith, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 97
Diagnosis of mast cell activation syndrome: a global “consensus-2”
Lawrence B. Afrin, Mary B. Ackerley, Linda S. Bluestein, et al.
Diagnosis (2020) Vol. 8, Iss. 2, pp. 137-152
Open Access | Times Cited: 81
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
Roberta Parente, Valentina Giudice, Chiara Cardamone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7071-7071
Open Access | Times Cited: 17
Mastocytosis and Mast Cell Activation Disorders: Clearing the Air
Clayton Webster Jackson, Cristina Marie Pratt, Chase Preston Rupprecht, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11270-11270
Open Access | Times Cited: 40
Mast Cell Activation Disorders
Arianna Giannetti, Emanuele Filice, Carlo Caffarelli, et al.
Medicina (2021) Vol. 57, Iss. 2, pp. 124-124
Open Access | Times Cited: 27
Tryptase in type I hypersensitivity
Moïse Michel, C. Klingebiel, Joana Vitte
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 2, pp. 169-177
Open Access | Times Cited: 19
67-Year-Old Man With Syncope
Jenny Jia Ling Cao, Nader Al-Shakarchi, Dayne Voelker
Mayo Clinic Proceedings (2025)
Closed Access
Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation Syndrome
Dayne Voelker, Thanai Pongdee
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 33-38
Closed Access | Times Cited: 3
Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management
Matthew J. Hamilton
Current Gastroenterology Reports (2024) Vol. 26, Iss. 4, pp. 107-114
Closed Access | Times Cited: 3
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
Robert W. Malone, Philip Tisdall, Philip Fremont‐Smith, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 27
Mast Cell Activation Syndrome Update—A Dermatological Perspective
Dana Mihele, Paul Nistor, Gabriela Bruma, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1116-1116
Open Access | Times Cited: 7
Anaphylaxis: Advances in the Past 10 Years
Catherine R. Weiler, Rik Schrijvers, David B.K. Golden
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 51-62
Closed Access | Times Cited: 10
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
Robert W. Malone, Philip Tisdall, Philip Fremont‐Smith, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 12
Mast cell activation syndrome: An up-to-date review of literature
Öner Özdemır, Gökçe Kasımoğlu, Ayşegül Bak, et al.
World Journal of Clinical Pediatrics (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review
Vito Sabato, Moïse Michel, Ulrich Blank, et al.
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 21, Iss. 5, pp. 426-434
Closed Access | Times Cited: 10
Mast Cell Biology and Linkages for Non-clonal Mast Cell Activation and Autoimmune/Inflammatory Syndrome Induced by Adjuvants
Nevio Cimolai
SN Comprehensive Clinical Medicine (2020) Vol. 2, Iss. 11, pp. 2310-2323
Closed Access | Times Cited: 9
Evaluation and Classification of Mast Cell Disorders: A Difficult to Manage Pathology in Clinical Practice
Polliana Mihaela Leru
Cureus (2022)
Open Access | Times Cited: 6
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
Robert W. Malone, Philip Tisdall, Philip Fremont‐Smith, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 7
Mast Cell Activation Disorders

The Journal of Allergy and Clinical Immunology In Practice (2014) Vol. 2, Iss. 3, pp. 258-258
Open Access | Times Cited: 5
Mast cells and mast cell activation syndrome: what's new?
Sofia Couto, Tiago Azenha Rama, Catarina Martins, et al.
Arquivos de Asmas Alergia e Imunologia (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 2
The many faces of pediatric urticaria
Bulent Enis Sekerel, Deniz İlgün Gürel, Ümit Murat Şahiner, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 2
Diagnostic de l’allergie aux venins d’hyménoptères
E Popin, J.P. Jacquier, Claude Lambert
Revue française d'allergologie (2021) Vol. 62, Iss. 1, pp. 44-51
Open Access | Times Cited: 5
The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease
Gerard E. Mullin, William D. Chey, Sheila E. Crowe, et al.
Gastroenterology (2020) Vol. 159, Iss. 1, pp. 20-25
Open Access | Times Cited: 4
Nutritional Implications of Mast Cell Diseases
Cheryl Harris, Bonnie Nasar, Celeste C. Finnerty
Journal of the Academy of Nutrition and Dietetics (2024) Vol. 124, Iss. 11, pp. 1387-1396
Closed Access
Physical Activity as a Trigger for Anaphylaxis: Understanding Food-Dependent Exercise-Induced Anaphylaxis
Kamila Szewczyk, Bartłomiej Szewczyk, Weronika Hołownia, et al.
Journal of Education Health and Sport (2024) Vol. 74, pp. 52562-52562
Open Access
Page 1 - Next Page

Scroll to top